NASDAQ:ELUT Elutia Q3 2026 Earnings Date & Estimates $0.80 -0.04 (-4.72%) Closing price 04:00 PM EasternExtended Trading$0.80 0.00 (-0.38%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Elutia is estimated to report Q3 2026 earnings on Thursday, November 5, 2026. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026Conference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Elutia in Q3 2026Elutia is expected to post earnings of -$0.15 per share on revenue of $1 million. In the same quarter a year earlier Elutia reported -$0.01 per share on revenue of $3.32 million. Elutia last reported on August 13, 2026, posting -$0.17 per share and missing the -$0.15 consensus estimate. Elutia has beaten the consensus EPS estimate in 1 of its last 6 quarters.Consensus EstimatesConsensus EPS-$0.15Expected Revenue$1 millionPrior-Year EPS-$0.01Prior-Year Revenue$3.32 millionExpected Revenue Growth-69.9%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.17 (Missed by -$0.02)Last Quarter Revenue$2.43 millionEPS Beat Rate1 of last 6 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Elutia Q3 2026 Earnings FAQ When does Elutia report Q3 2026 earnings? Elutia (NASDAQ:ELUT) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Elutia's Q3 2026 earnings call? Elutia's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Elutia? Analysts expect Elutia to post earnings of -$0.15 per share for Q3 2026. How much revenue is Elutia expected to report? The consensus revenue estimate for Elutia is $1 million for Q3 2026. Elutia Earnings HeadlinesElutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026October 22, 2026 | globenewswire.comHead to Head Contrast: Elutia (NASDAQ:ELUT) and QuidelOrtho (NASDAQ:QDEL)October 20, 2026 | americanbankingnews.comEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon. A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years.October 26 at 1:00 AM | Behind the Markets (Ad)Elutia Inc.: Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029October 2, 2026 | finanznachrichten.deElutia Reports $8 Million Payment from Boston ScientificOctober 1, 2026 | marketscreener.comMElutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029October 1, 2026 | globenewswire.comSee More Elutia Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Elutia? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elutia and other key companies, straight to your email. Email Address About ElutiaElutia (NASDAQ:ELUT) is a medical technology company focused on developing and commercializing biologic products designed to support tissue healing and improve the performance of implantable medical devices. The company combines human tissue-based materials with drug-delivery and regenerative medicine technologies. Its product portfolio includes biologic envelopes used to protect and support cardiac implantable electronic devices, including pacemakers and defibrillators. Elutia also develops tissue matrices and other biologic products for orthopedic, wound care and related surgical applications, with products intended to support soft-tissue repair, reconstruction and healing. The company was formerly known as Aziyo Biologics and adopted the Elutia name as part of its broader focus on bioelectronic medicine and regenerative healthcare. Elutia serves medical-device manufacturers, hospitals, surgeons and other healthcare providers, primarily through commercial operations in the United States.View Elutia ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Anthropic's IPO Filing Reveals a Massive Opportunity for AI Infrastructure GiantsBristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own StockBuy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big CatalystsComfort Systems Earnings: AI Slowdown or More Growth Ahead?MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline Upcoming Earnings Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Baker Hughes (10/27/2026)ONEOK (10/27/2026)Robinhood Markets (10/27/2026)HSBC (10/27/2026)S&P Global (10/27/2026)Visa (10/27/2026)HCA Healthcare (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
